Previous 10 | Next 10 |
MORRISVILLE, N.C., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it was awarded the Society for Clinical Research Sites (SCRS) Ea g le Award , sweeping the CRO ca...
MORRISVILLE, N.C., Oct. 05, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its third quarter 2020 financial results on Thursday, October 29, 2020, prior to its earnings call at 8:00 a.m. ET. ...
Biopharmaceutical solutions organization, Syneos Health ([[SYNH]] +5.4%) has been upgraded to Buy from Neutral at Goldman Sachs with a price target of $75 (33% upside), up from $69.According to analyst, Syneos's shares have underperformed (dipped 14%) over the past month, which does not refle...
The following slide deck was published by Syneos Health, Inc. in conjunction with this event. For further details see: Syneos Health (SYNH) Presents At Baird 2020 Global Healthcare Conference
Syneos Health (NASDAQ: SYNH ) -5.1% PM , priced its earlier announced underwritten secondary offering of 7M shares at $59.75/share. More news on: Syneos Health, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
MORRISVILLE, N.C., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Co...
Syneos Health (NASDAQ: SYNH ) has commenced an underwritten secondary offering by Thomas H. Lee Partners and Advent of 7M common shares More news on: Syneos Health, Inc., Healthcare stocks news, , Read more ...
MORRISVILLE, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Co...
MORRISVILLE, N.C., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that the Companyȁ...
MORRISVILLE, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced that Chief Executive O...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...